Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qili Shi

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Cell Death & Disease|May 6, 2025
Correction: The liver-specific long noncoding RNA FAM99B inhibits ribosome biogenesis and cancer progression through cleavage of dead-box Helicase 21Yifei He, Hongquan Li, Qili Shi, et al.
Cell Death & Disease|February 14, 2025
The liver-specific long noncoding RNA FAM99B inhibits ribosome biogenesis and cancer progression through cleavage of dead-box Helicase 21Yifei He, Hongquan Li, Qili Shi, et al.
Food Research International (Ottawa, Ont.)|September 10, 2023
Metagenomic analyses reveal microbial communities and functional differences between Daqu from seven provincesChutian Zhu, Yuxin Cheng, Qili Shi, et al.
Biomarker Research|April 27, 2022
SRTdb: an omnibus for human tissue and cancer-specific RNA transcriptsQili Shi, Teng Liu, Wei Hu, et al.
Japanese Journal of Clinical Oncology|March 31, 2019
The prognostic signature of the somatic mutations in Ewing sarcoma: from a network viewYuehui Zhang, Jia Song, Qili Shi, et al.
Science China. Life Sciences|January 13, 2026
Mitochondrial LINC00942 activates complex I and inhibits ferroptosis through interacting with GRSF1 in liver cancerYina Liao, Yue Su, Yanfang Liu, et al.
Computers in Biology and Medicine|March 14, 2022
A pathway-guided strategy identifies a metabolic signature for prognosis prediction and precision therapy for hepatocellular carcinomaQili Shi, Yizhe Liu, Mingxing Lu, et al.
Clinical and Translational Medicine|December 3, 2024
Glucose-induced LINC01419 reprograms the glycolytic pathway by recruiting YBX1 to enhance PDK1 mRNA stability in hepatocellular carcinomaYanfang Liu, Junjiao Song, Qili Shi, et al.
Cancer Letters|August 25, 2024
Fibrillarin reprograms glucose metabolism by driving the enhancer-mediated transcription of PFKFB4 in liver cancerYizhe Liu, Qili Shi, Yanfang Liu, et al.
Epigenetics|March 19, 2019
Integrative analysis identifies DNMTs against immune-infiltrating neutrophils and dendritic cells in colorectal cancerQili Shi, Libing Shen, Jun Gan, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Cell Death & Disease|May 6, 2025
Correction: The liver-specific long noncoding RNA FAM99B inhibits ribosome biogenesis and cancer progression through cleavage of dead-box Helicase 21Yifei He, Hongquan Li, Qili Shi, et al.
Cell Death & Disease|February 14, 2025
The liver-specific long noncoding RNA FAM99B inhibits ribosome biogenesis and cancer progression through cleavage of dead-box Helicase 21Yifei He, Hongquan Li, Qili Shi, et al.
Food Research International (Ottawa, Ont.)|September 10, 2023
Metagenomic analyses reveal microbial communities and functional differences between Daqu from seven provincesChutian Zhu, Yuxin Cheng, Qili Shi, et al.
Biomarker Research|April 27, 2022
SRTdb: an omnibus for human tissue and cancer-specific RNA transcriptsQili Shi, Teng Liu, Wei Hu, et al.
Japanese Journal of Clinical Oncology|March 31, 2019
The prognostic signature of the somatic mutations in Ewing sarcoma: from a network viewYuehui Zhang, Jia Song, Qili Shi, et al.
Science China. Life Sciences|January 13, 2026
Mitochondrial LINC00942 activates complex I and inhibits ferroptosis through interacting with GRSF1 in liver cancerYina Liao, Yue Su, Yanfang Liu, et al.
Computers in Biology and Medicine|March 14, 2022
A pathway-guided strategy identifies a metabolic signature for prognosis prediction and precision therapy for hepatocellular carcinomaQili Shi, Yizhe Liu, Mingxing Lu, et al.
Clinical and Translational Medicine|December 3, 2024
Glucose-induced LINC01419 reprograms the glycolytic pathway by recruiting YBX1 to enhance PDK1 mRNA stability in hepatocellular carcinomaYanfang Liu, Junjiao Song, Qili Shi, et al.
Cancer Letters|August 25, 2024
Fibrillarin reprograms glucose metabolism by driving the enhancer-mediated transcription of PFKFB4 in liver cancerYizhe Liu, Qili Shi, Yanfang Liu, et al.
Epigenetics|March 19, 2019
Integrative analysis identifies DNMTs against immune-infiltrating neutrophils and dendritic cells in colorectal cancerQili Shi, Libing Shen, Jun Gan, et al.
Pageof 3